Sheetal Hardikar1,2, Andrea N Burnett-Hartman3,4, Jessica Chubak5, Melissa P Upton6, Lee-Ching Zhu5, John D Potter3,7,8, Polly A Newcomb3,7. 1. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., M4-B402, PO Box 19024, Seattle, WA, 98109-1024, USA. shardika@fhcrc.org. 2. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. shardika@fhcrc.org. 3. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., M4-B402, PO Box 19024, Seattle, WA, 98109-1024, USA. 4. Kaiser Permanente, Colorado Institute for Health Research, Denver, CO, USA. 5. Group Health Research Institute, Seattle, WA, USA. 6. Department of Pathology, School of Medicine, University of Washington, Seattle, WA, USA. 7. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. 8. Centre for Public Health Research, Massey University, Wellington, New Zealand.
Abstract
BACKGROUND: Oral contraceptives (OC) are associated with a decreased risk of colorectal cancers; however, a recent study reported an increased risk of small colorectal adenomas associated with OC use. To determine if these results were replicable in a different study population, we investigated the relationship between OC use and other reproductive factors and risk of colorectal polyps in a case-control study in western Washington. METHODS: Study participants were 24-79-year-old female enrollees at an integrated health care system in western Washington who were diagnosed as having adenomas (n = 299), serrated polyps (n = 337), both types of polyps (n = 105) or as polyp-free controls (n = 615) through an index colonoscopy and completed a structured interview to collect reproductive history information. Multivariable polytomous logistic regression was used to compare case groups to controls and to each other; odds ratios (OR) and 95% confidence intervals were estimated. RESULTS: There was no association between OC use, duration of use, or recency of use and the risk of either adenomas or serrated polyps [adjusted OR for OC ever use (95% CI) 0.85 (0.58-1.23) and 0.96 (0.66-1.40), respectively], and associations did not differ by lesion severity within the adenoma or serrated pathways. Further, no associations were observed between other reproductive factors and risk of colorectal polyp subtypes. CONCLUSIONS: Our results suggest that reproductive factors, including OC use, are not associated with early colorectal cancer precursor lesions.
BACKGROUND: Oral contraceptives (OC) are associated with a decreased risk of colorectal cancers; however, a recent study reported an increased risk of small colorectal adenomas associated with OC use. To determine if these results were replicable in a different study population, we investigated the relationship between OC use and other reproductive factors and risk of colorectal polyps in a case-control study in western Washington. METHODS: Study participants were 24-79-year-old female enrollees at an integrated health care system in western Washington who were diagnosed as having adenomas (n = 299), serrated polyps (n = 337), both types of polyps (n = 105) or as polyp-free controls (n = 615) through an index colonoscopy and completed a structured interview to collect reproductive history information. Multivariable polytomous logistic regression was used to compare case groups to controls and to each other; odds ratios (OR) and 95% confidence intervals were estimated. RESULTS: There was no association between OC use, duration of use, or recency of use and the risk of either adenomas or serrated polyps [adjusted OR for OC ever use (95% CI) 0.85 (0.58-1.23) and 0.96 (0.66-1.40), respectively], and associations did not differ by lesion severity within the adenoma or serrated pathways. Further, no associations were observed between other reproductive factors and risk of colorectal polyp subtypes. CONCLUSIONS: Our results suggest that reproductive factors, including OC use, are not associated with early colorectal cancer precursor lesions.
Authors: Brittany M Charlton; Kana Wu; Xuehong Zhang; Edward L Giovannucci; Charles S Fuchs; Stacey A Missmer; Bernard Rosner; Susan E Hankinson; Walter C Willett; Karin B Michels Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-10 Impact factor: 4.254
Authors: Libby M Morimoto; Polly A Newcomb; Cornelia M Ulrich; Roberd M Bostick; Cynthia J Lais; John D Potter Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-10 Impact factor: 4.254
Authors: Hazel B Nichols; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: E A Platz; M E Martinez; F Grodstein; C S Fuchs; G A Colditz; M J Stampfer; E Giovannucci Journal: Cancer Causes Control Date: 1997-11 Impact factor: 2.506
Authors: Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb Journal: Am J Epidemiol Date: 2013-03-03 Impact factor: 4.897
Authors: Michael S Simon; Rowan T Chlebowski; Jean Wactawski-Wende; Karen C Johnson; Andrew Muskovitz; Ikuko Kato; Alicia Young; F Allan Hubbell; Ross L Prentice Journal: J Clin Oncol Date: 2012-09-24 Impact factor: 44.544
Authors: Brittany M Charlton; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Jung Eun Lee; Yin Cao; Stacey A Missmer; Bernard A Rosner; Susan E Hankinson; Walter Willett; Kana Wu; Karin B Michels Journal: Cancer Causes Control Date: 2016-04-28 Impact factor: 2.506
Authors: J S Jacobson; A I Neugut; G C Garbowski; H Ahsan; J D Waye; M R Treat; K A Forde Journal: Cancer Causes Control Date: 1995-11 Impact factor: 2.506